These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1856789)

  • 1. HIV-1 proviral copy number in blood mononuclear cells from AIDS patients on zidovudine therapy.
    Donovan RM; Dickover RE; Goldstein E; Huth RG; Carlson JR
    J Acquir Immune Defic Syndr (1988); 1991; 4(8):766-9. PubMed ID: 1856789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood mononuclear cell human immunodeficiency virus type 1 proviral DNA quantification by polymerase chain reaction: relationship to immunodeficiency and drug effect.
    Montoya JG; Wood R; Katzenstein D; Holodny M; Merigan TC
    J Clin Microbiol; 1993 Oct; 31(10):2692-6. PubMed ID: 7902845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine and human rIL-2 administration.
    Clark AG; Holodniy M; Schwartz DH; Katzenstein DA; Merigan TC
    J Acquir Immune Defic Syndr (1988); 1992; 5(1):52-9. PubMed ID: 1738087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreases in unintegrated HIV DNA are associated with antiretroviral therapy in AIDS patients.
    Dickover RE; Donovan RM; Goldstein E; Cohen SH; Bolton V; Huth RG; Liu GZ; Carlson JR
    J Acquir Immune Defic Syndr (1988); 1992; 5(1):31-6. PubMed ID: 1310734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus proviral DNA from peripheral blood and lymph nodes demonstrates concordant resistance mutations to zidovudine (codon 215) and didanosine (codon 74). Division of AIDS Treatment Research Initiative 003 Study Group.
    Mayers D; Bethel J; Wainberg MA; Weislow O; Schnittman S
    J Infect Dis; 1998 Jun; 177(6):1730-3. PubMed ID: 9607859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative estimation of human immunodeficiency virus type-1 provirus in CD4+ T lymphocytes using the polymerase chain reaction.
    Oka S; Urayama K; Hirabayashi Y; Ohnishi K; Goto H; Mitamura K; Kimura S; Shimada K
    Mol Cell Probes; 1991 Apr; 5(2):137-42. PubMed ID: 1830129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of HIV-1 proviral DNA in peripheral blood mononuclear cells from patients with AIDS or ARC: decrease of proviral DNA content following treatment with 2',3'-dideoxyinosine (ddI).
    Aoki S; Yarchoan R; Thomas RV; Pluda JM; Marczyk K; Broder S; Mitsuya H
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1331-9. PubMed ID: 2127682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of HIV-1 infection. Monitoring of HIV-1 DNA in peripheral blood mononuclear cells by PCR.
    Hufert FT; von Laer D; Fenner TE; Schwander S; Kern P; Schmitz H
    Arch Virol; 1991; 120(3-4):233-40. PubMed ID: 1683531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 proviral DNA copy number in peripheral blood leucocytes and bronchoalveolar lavage cells of AIDS patients.
    Clarke JR; Gates AJ; Coker RJ; Douglass JA; Williamson JD; Mitchell DM
    Clin Exp Immunol; 1994 May; 96(2):182-6. PubMed ID: 8187325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zidovudine-resistant human immunodeficiency virus type 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells.
    Smith MS; Koerber KL; Pagano JS
    J Infect Dis; 1993 Feb; 167(2):445-8. PubMed ID: 7678429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative differences in the distribution of zidovudine resistance mutations in multiple post-mortem tissues from AIDS patients.
    Atkins M; Strappe P; Kaye S; Loveday C; McLaughlin JE; Johnson MA; Tedder RS; Griffiths PD; Emery VC
    J Med Virol; 1998 Jun; 55(2):138-46. PubMed ID: 9598935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of HIV-1 proviral DNA by a standardized colorimetric PCR-based assay.
    Izopet J; Tamalet C; Pasquier C; Sandres K; Marchou B; Massip P; Puel J
    J Med Virol; 1998 Jan; 54(1):54-9. PubMed ID: 9443109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of HIV-1 DNA in different subsets of human peripheral blood mononuclear cells using the polymerase chain reaction. Rapid communication.
    Hufert FT; von Laer D; Schramm C; Tárnok A; Schmitz H
    Arch Virol; 1989; 106(3-4):341-5. PubMed ID: 2570562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a new predictor of AIDS progression through the quantitation of HIV-1 DNA copies by PCR in HIV-infected individuals.
    Lefrère JJ; Mariotti M; Wattel E; Lefrère F; Inchauspe G; Costagliola D; Prince A
    Br J Haematol; 1992 Oct; 82(2):467-71. PubMed ID: 1419830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients.
    Kozal MJ; Shafer RW; Winters MA; Katzenstein DA; Aguiniga E; Halpern J; Merigan TC
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):832-8. PubMed ID: 7517448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus.
    Aleixo LF; Goodenow MM; Sleasman JW
    J Pediatr; 1997 Jun; 130(6):906-14. PubMed ID: 9202612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of drug-related genotypic changes in HIV-1 from serum using the selective polymerase chain reaction.
    Anderson BD; Shirasaka T; Kojima E; Yarchoan R; Mitsuya H
    Antiviral Res; 1994 Dec; 25(3-4):245-58. PubMed ID: 7710271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team.
    Sáez-Llorens X; Nelson RP; Emmanuel P; Wiznia A; Mitchell C; Church JA; Sleasman J; Van Dyke R; Richardson CG; Cutrell A; Spreen W; Hetherington S
    Pediatrics; 2001 Jan; 107(1):E4. PubMed ID: 11134468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The appearance of drug resistance-associated point mutations in HIV type 1 plasma RNA precedes their appearance in proviral DNA.
    Kaye S; Comber E; Tenant-Flowers M; Loveday C
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1221-5. PubMed ID: 8573378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification and comparison of HIV-1 proviral load in peripheral blood mononuclear cells and isolated CD4+ T cells.
    Wood R; Dong H; Katzenstein DA; Merigan TC
    J Acquir Immune Defic Syndr (1988); 1993 Mar; 6(3):237-40. PubMed ID: 8450397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.